Litcius/Paper detail

COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan

Balraj Singh, Parminder Kaur, Vinod Kumar, Michael Maroules

2021Radiology Case Reports17 citationsDOIOpen Access PDF

Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the ongoing global pandemic. It can manifest a wide range of complications depending upon the severity of infection and comorbidities of the patient. Vaccines are very important measure to provide protection against COVID-19. We report a case of 72-year-old female with past medical history of hypertension and diabetes mellitus who underwent imaging with positron emission tomography (PET) scan imaging for staging of her small cell urinary bladder cancer and was found to have hypermetabolic uptake in the deltoid muscle of the left shoulder and hypermetabolic left axillary and pectoral lymph nodes due to mRNA BNT-162b2 (Pfizer-BioNTech COVID-19 vaccine) vaccine administrated 3 days ago prior to PET scan.

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)Positron emission tomographyRadiologyMediastinal lymphadenopathyAxillary LymphadenopathyDiabetes mellitusPathologyComputed tomographyDiseaseBreast cancerInternal medicineCancerInfectious disease (medical specialty)EndocrinologyLymphadenopathy Diagnosis and AnalysisHeparin-Induced Thrombocytopenia and ThrombosisMusculoskeletal synovial abnormalities and treatments
COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan | Litcius